T0	KEYPHRASE-NOTYPES 0 14	Histopathology,"","of "
T1	KEYPHRASE-NOTYPES 18 51	peripheral nerve biopsy specimens," of","fro"
T2	KEYPHRASE-NOTYPES 57 65	patients,"rom","wit"
T3	KEYPHRASE-NOTYPES 71 98	neurological manifestations,"ith","of "
T4	KEYPHRASE-NOTYPES 102 114	Lyme disease," of","sho"
T5	KEYPHRASE-NOTYPES 123 146	perivascular infiltrate,"s a","of "
T6	KEYPHRASE-NOTYPES 150 161	lymphocytes," of"," pl"
T7	KEYPHRASE-NOTYPES 163 175	plasma cells,"es,","and"
T8	KEYPHRASE-NOTYPES 180 191	histiocytes,"and","in "
T9	KEYPHRASE-NOTYPES 195 206	association," in","wit"
T10	KEYPHRASE-NOTYPES 212 249	patchy multifocal axonal degeneration,"ith","[17"
T11	KEYPHRASE-NOTYPES 267 289	lymphocytic infiltrate,". A","has"
T12	KEYPHRASE-NOTYPES 320 328	meninges,"the","[36"
T13	KEYPHRASE-NOTYPES 365 376	gray matter,"and","in "
T14	KEYPHRASE-NOTYPES 383 396	advanced case," an"," al"
T15	KEYPHRASE-NOTYPES 409 421	infiltration,"ith","of "
T16	KEYPHRASE-NOTYPES 425 444	dorsal root ganglia," of","and"
T17	KEYPHRASE-NOTYPES 449 460	nerve roots,"and","[48"
T18	KEYPHRASE-NOTYPES 509 521	immune cells,"ing","als"
T19	KEYPHRASE-NOTYPES 545 555	production,"the","of "
T20	KEYPHRASE-NOTYPES 576 597	neurotoxic substances,"and"," T-"
T21	KEYPHRASE-NOTYPES 599 611	T-cell lines,"es.","and"
T22	KEYPHRASE-NOTYPES 616 622	clones,"and","iso"
T23	KEYPHRASE-NOTYPES 641 644	CSF,"the","of "
T24	KEYPHRASE-NOTYPES 648 656	patients," of","wit"
T25	KEYPHRASE-NOTYPES 662 665	LNB,"ith","sho"
T26	KEYPHRASE-NOTYPES 673 692	strong polarization,"w a","tow"
T27	KEYPHRASE-NOTYPES 703 707	type,"s a","1 c"
T28	KEYPHRASE-NOTYPES 710 726	cytokine pattern,"e 1","(hi"
T29	KEYPHRASE-NOTYPES 728 743	high production,"rn ","of "
T30	KEYPHRASE-NOTYPES 747 751	IFNg," of","and"
T31	KEYPHRASE-NOTYPES 763 782	undetectable levels,"tly","of "
T32	KEYPHRASE-NOTYPES 786 790	IL-4," of"," [4"
T33	KEYPHRASE-NOTYPES 808 829	CSF mononuclear cells,"hen","(MN"
T34	KEYPHRASE-NOTYPES 831 834	MNC,"ls "," fr"
T35	KEYPHRASE-NOTYPES 841 855	adult patients,"rom","wit"
T36	KEYPHRASE-NOTYPES 861 864	LNB,"ith","are"
T37	KEYPHRASE-NOTYPES 885 903	borrelial antigens,"ith","in "
T38	KEYPHRASE-NOTYPES 925 944	marked upregulation,"s a","of "
T39	KEYPHRASE-NOTYPES 952 958	number,"the","of "
T40	KEYPHRASE-NOTYPES 962 981	IFNgsecreting cells," of","[49"
T41	KEYPHRASE-NOTYPES 1002 1014	upregulation,"his","is "
T42	KEYPHRASE-NOTYPES 1052 1068	peripheral blood," to"," su"
T43	KEYPHRASE-NOTYPES 1083 1110	strong compartmentalization,"g a","of "
T44	KEYPHRASE-NOTYPES 1118 1149	Borrelia-specific IFNg response,"the","[49"
T45	KEYPHRASE-NOTYPES 1174 1180	number,"the","of "
T46	KEYPHRASE-NOTYPES 1184 1199	responder cells," of","sho"
T47	KEYPHRASE-NOTYPES 1206 1226	pronounced variation,"ows","bet"
T48	KEYPHRASE-NOTYPES 1235 1243	patients,"een","[49"
T49	KEYPHRASE-NOTYPES 1245 1252	490e494,"ts ",", a"
T50	KEYPHRASE-NOTYPES 1265 1279	concentrations,"the","of "
T51	KEYPHRASE-NOTYPES 1283 1287	IFNg," of","and"
T52	KEYPHRASE-NOTYPES 1308 1323	cytokines,"all","and"
T53	KEYPHRASE-NOTYPES 1328 1338	chemokines,"and","tha"
T54	KEYPHRASE-NOTYPES 1366 1369	CSF," in","of "
T55	KEYPHRASE-NOTYPES 1373 1381	patients," of","wit"
T56	KEYPHRASE-NOTYPES 1387 1390	LNB,"ith","[49"
T57	KEYPHRASE-NOTYPES 1392 1399	495e497,"NB ",". T"
T58	KEYPHRASE-NOTYPES 1406 1427	actual concentrations,"The","of "
T59	KEYPHRASE-NOTYPES 1431 1435	IFNg," of","in "
T60	KEYPHRASE-NOTYPES 1439 1442	CSF," in","are"
T61	KEYPHRASE-NOTYPES 1487 1499	CD8þ cells,"ave","bee"
T62	KEYPHRASE-NOTYPES 1517 1537	nerve biopsy samples," in","fro"
T63	KEYPHRASE-NOTYPES 1543 1551	patients,"rom","wit"
T64	KEYPHRASE-NOTYPES 1557 1586	ACA-associated polyneuropathy,"ith","[21"
T65	KEYPHRASE-NOTYPES 1598 1614	clonal expansion,"but","of "
T66	KEYPHRASE-NOTYPES 1618 1629	CD8 cells," of","has"
T67	KEYPHRASE-NOTYPES 1659 1662	CSF,"the","of "
T68	KEYPHRASE-NOTYPES 1666 1674	patients," of","wit"
T69	KEYPHRASE-NOTYPES 1680 1689	acute LNB,"ith","[49"
T70	KEYPHRASE-NOTYPES 1710 1716	clones,"ded","pro"
T71	KEYPHRASE-NOTYPES 1726 1730	TNFa,"ced","and"
T72	KEYPHRASE-NOTYPES 1740 1744	IFNg,"ome","in "
T73	KEYPHRASE-NOTYPES 1748 1756	response," in","to "
T74	KEYPHRASE-NOTYPES 1760 1771	stimulation," to","wit"
T75	KEYPHRASE-NOTYPES 1786 1794	antigens,"lia"," Wh"
T76	KEYPHRASE-NOTYPES 1806 1810	role,"the","of "
T77	KEYPHRASE-NOTYPES 1820 1850	Borrelia-specific CD8þ cells,"ese","in "
T78	KEYPHRASE-NOTYPES 1854 1857	LNB," in","rem"
T79	KEYPHRASE-NOTYPES 1891 1900	detection,"eir","in "
T80	KEYPHRASE-NOTYPES 1904 1911	tissues," in","tha"
T81	KEYPHRASE-NOTYPES 1950 1959	infection,"lia","sug"
T82	KEYPHRASE-NOTYPES 1971 1975	role,"s a","in "
T83	KEYPHRASE-NOTYPES 1979 1997	early host defense," in"," On"
T84	KEYPHRASE-NOTYPES 2006 2016	hand,"the"," pe"
T85	KEYPHRASE-NOTYPES 2018 2033	peripheral CD8þ,"nd,","and"
T86	KEYPHRASE-NOTYPES 2038 2048	gd cells,"and","wer"
T87	KEYPHRASE-NOTYPES 2072 2091	predominant sources,"the","of "
T88	KEYPHRASE-NOTYPES 2095 2128	Borrelia-specific IFNg production," of","in "
T89	KEYPHRASE-NOTYPES 2132 2140	patients," in","wit"
T90	KEYPHRASE-NOTYPES 2146 2170	chronic Lyme borreliosis,"ith","(mo"
T91	KEYPHRASE-NOTYPES 2179 2182	LNB,"tly"," [4"
T92	KEYPHRASE-NOTYPES 2194 2198	view," In","of "
T93	KEYPHRASE-NOTYPES 2206 2237	strong CSF compartmentalization,"the","of "
T94	KEYPHRASE-NOTYPES 2245 2260	immune response,"the"," th"
T95	KEYPHRASE-NOTYPES 2266 2275	relevance,"the","of "
T96	KEYPHRASE-NOTYPES 2285 2293	findings,"ese","is "
T97	KEYPHRASE-NOTYPES 2313 2325	precise role,"the","of "
T98	KEYPHRASE-NOTYPES 2334 2347	cell subset,"his","rem"
